JAC Advance Access originally published online on September 29, 2006
Journal of Antimicrobial Chemotherapy 2006 58(6):1295-1298; doi:10.1093/jac/dkl395
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Combined antifungal therapy in a murine infection by Candida glabrata
Unitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili Carrer Sant Llorenç 21, 43201, Reus, Spain
Received 28 June 2006; returned 12 August 2006; revised 24 August 2006; accepted 9 September 2006
*Corresponding author. Tel: +34-977-759359; Fax: +34-977-759322; E-mail: franciscojavier.pastor{at}urv.cat
Objectives: To develop proper treatments for patients who do not respond to current antifungal treatments, we tested new combinations of antifungal drugs for treating disseminated infections by Candida glabrata in a murine model.
Methods: Mice were rendered neutropenic by intraperitoneal cyclophosphamide and intravenous 5-fluorouracil administration. The animals were infected intravenously with 2 x 108 cfu of C. glabrata. The efficacies of micafungin combined with amphotericin B, fluconazole or flucytosine, and of amphotericin B combined with fluconazole were evaluated by survival and tissue burden reduction.
Results and Conclusions: Micafungin plus amphotericin B was the most effective combination at reducing tissue burden. Micafungin at 10 mg/kg combined with amphotericin B at 0.75, 1.5 or 3 mg/kg prolonged survival with respect to the monotherapies, but only the second combination showed a synergistic effect in reducing fungal load in spleen and kidney. Amphotericin B at 1.5 mg/kg combined with micafungin at 5, 10 or 20 mg/kg reduced tissue burden with respect to the monotherapies, but the effects of the three combinations were very similar. These results suggest that amphotericin B in combination with micafungin is promising for the treatment of disseminated C. glabrata infections.
Keywords: candidiasis , animal models , micafungin , fluconazole , flucytosine
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Kiraz, I. Dag, M. Yamac, A. Kiremitci, N. Kasifoglu, and Y. Akgun Antifungal Activity of Caspofungin in Combination with Amphotericin B against Candida glabrata: Comparison of Disk Diffusion, Etest, and Time-Kill Methods Antimicrob. Agents Chemother., February 1, 2009; 53(2): 788 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Serena, M. M. Rodriguez, M. Marine, F. J. Pastor, and J. Guarro Micafungin combined with fluconazole, an effective therapy for murine blastoschizomycosis J. Antimicrob. Chemother., April 1, 2008; 61(4): 877 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Serena, M. Marine, G. Quindos, A. J. Carrillo, J. F. Cano, F. J. Pastor, and J. Guarro In Vitro Interactions of Micafungin with Amphotericin B against Clinical Isolates of Candida spp. Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1529 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Rodriguez, M. Ruiz, F. J. Pastor, G. Quindos, A. Carrillo, and J. Guarro In vitro interaction of micafungin and fluconazole against Candida J. Antimicrob. Chemother., July 1, 2007; 60(1): 188 - 190. [Full Text] [PDF] |
||||

